Development of tolerance to the antinociceptive effect of systemic morphine at the lumbar spinal cord level: A c-Fos study in the rat

Brain Research

Volumn 813, Issue 1, 1998, Pages 128-138

  Guen, Stéphanie Le ^a   Catheline, Gwénaëlle ^a   Besson, Jean Marie ^a  

^a PSL RESEARCH UNIVERSITY   (France)

Author keywords

Antinociception; c Fos; Carrageenin; Dose response; Morphine tolerance; Spinal cord

Indexed keywords

ANTINOCICEPTIVE AGENT; CARRAGEENAN; MORPHINE; PROTEIN C FOS;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG TOLERANCE; IMMUNOREACTIVITY; INTRAVENOUS DRUG ADMINISTRATION; LUMBAR SPINAL CORD; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; SPINAL CORD NERVE CELL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANALGESICS, OPIOID; ANIMALS; CARRAGEENAN; DRUG TOLERANCE; EXCIPIENTS; HYPERALGESIA; INFLAMMATION; LUMBOSACRAL REGION; MALE; MORPHINE; NERVE TISSUE PROTEINS; PAIN; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; REGRESSION ANALYSIS; SPINAL CORD;

EID: 0032583257     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)01012-9     Document Type: Article

References (77)

1. Abbadie C., Besson J.-M. Effects of morphine and naloxone on basal and evoked Fos-like immunoreactivity in lumbar spinal cord neurons of arthritic rats. Pain. 52:1993;29-39.
2. Abbadie C., Honoré P., Fournié-Zaluski M.-C., Roques B.P., Besson J.-M. Effects of opioids and non-opioids on c-Fos immunoreactivity induced in rat lumbar spinal cord neurons by noxious heat stimulation. Eur. J. Pharmacol. 258:1994;215-227.
3. Advokat C., Burton P., Tyler C.B. Investigation of tolerance to chronic intrathecal morphine infusion in the rat. Physiol. Behav. 39:1987;161-168.
4. Aley K.O., Green P.G., Levine J.D. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J. Neurosci. 15:1995;8031-8038.
5. Aley K.O., Levine J.D. Different mechanisms mediate development and expression of tolerance and dependence for peripheral μ-opioid antinociception in rat. J. Neurosci. 17(20):1997;8018-8023.
6. Basbaum A.I., Fields H.L. Endogenous pain control mechanisms: review and hypothesis. Ann. Neurol. 4:1978;451-462.
7. Berge O.-G., Hole K. Tolerance to the antinociceptive effect of morphine in the spinal rat. Neuropharmacology. 20:1981;653-657.
8. Besse D., Lombard M.-C., Zajac J.-M., Roques B.P., Besson J.-M. Pre- and postsynaptic distribution of μ, ∂ and κ opioid receptors in the superficial layers of the cervical dorsal horn of the rat spinal cord. Brain Res. 521:1990;15-22.
9. Besson J.-M., Chaouch A. Peripheral and spinal mechanisms of nociception. Physiol. Rev. 67:1987;67-186.
10. J.-M. Besson, D. Le Bars, Effects of morphine on the transmission of painful messages at the spinal level, in: M. Adler, L. Manara, R. Samanin (Eds.), Factors Affecting the Action of Narcotics, RavenPress, New York, 1978, pp. 103-124.
11. Bouhassira D., Villanueva L., Le Bars D. Intracerebroventricular morphine decreases descending inhibitions acting on lumbar dorsal horn neuronal activities related to pain in the rat. J. Pharmacol. Exp. Ther. 247(1):1988;332-342.
12. Bullitt E., Lee C.L., Light A.R., Willcockson H.H. The effect of stimulus duration on noxious-stimulus induced c-fos expression in the rodent spinal cord. Brain Res. 580:1992;170-172.
13. V. Chapman, J.-M. Besson, Pharmacological studies of nociceptive systems using the c-Fos immunohistochemical technique: an indicator of noxiously activated spinal neurones, in: A.H. Dickenson, J.-M. Besson (Eds.), Handbook of Experimental Pharmacology: The Pharmacology of Pain, Vol. 130, Springer-Verlag, Berlin Heidelberg, 1997, pp. 235-279.
14. Chaudhuri A. Neural activity mapping with inducible transcription factors. NeuroReport. 8(13):1997;R3-R7.
15. Coggeshall R.E., Zhou S., Carlton S.M. Opioid receptors on peripheral sensory axons. Brain Res. 764:1997;126-132.
16. Collier H.O.J., Francis D.L., Schneider C. Modification of morphine withdrawal by drugs interacting with humoral mechanisms: some contradictions and their interpretation. Nature. 237:1972;220-223.
17. Collin E., Cesselin F. Neurobiological mechanisms of opioid tolerance and dependence. Clin. Neuropharmacol. 14(6):1991;465-488.
18. Cox L.S., Tiffany S.T. Associative and nonassociative tolerance: the effects of dose and interdose interval. Pharmacol. Biochem. Behav. 57(1/2):1997;31-36.
19. Crain S.M. Spinal cord tissue culture models for analyses of opioid analgesia, tolerance and plasticity. NIDA Res. Monogr. 54:1984;260-292.
20. Crain S.M., Crain B., Finnigan T., Simon E.J. Development of tolerance to opiates and opioid peptides in organotypic cultures of mouse spinal cord. Life Sci. 25:1979;1797-1802.
21. Curran T., Morgan J.I. Fos: an immediate-early transcription factor in neurons. J. Neurobiol. 26(3):1995;403-412.
22. Delander G.E., Portoghese P.S., Takemori A.E. Role of spinal μ opioid receptors in the development of morphine tolerance and dependence. J. Pharmacol. Exp. Ther. 231:1984;91-96.
23. Delander G.E., Takemori A.E. Spinal antagonism of tolerance and dependence induced by systemically administered morphine. Eur. J. Pharmacol. 94:1983;35-42.
24. A.H. Dickenson, Where and how do opioids act?, in: G.F. Gebhart, D.L. Hammond, T.S. Jensen (Eds.), Proceedings of the 7th World Congress on Pain, Progress in Pain Research and Management, Vol. 2, IASP Press, Seattle, 1994, pp. 525-552.
25. A.H. Dickenson, J.-M. Besson, Handbook of Experimental Pharmacology: The Pharmacology of Pain, Vol. 130, Springer-Verlag, Berlin Heidelberg, 1997.
26. Draisci G., Iadarola M.J. Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. Mol. Brain Res. 6:1989;31-37.
27. Duggan A.W., North R.A. Electrophysiology of opioids. Pharmacol. Rev. 35(4):1984;219-281.
28. Ekblom M., Hammarlund-Udenaes M., Paalzow L. Modeling of tolerance development and rebound effect during different intravenous administrations of morphine to rats. J. Pharmacol. Exp. Ther. 266(1):1993;244-252.
29. Ferreira S.H., Lorenzetti B.B., Rae G.A. Is methylnalorphinium the prototype of an ideal peripheral analgesic? Eur. J. Pharmacol. 99:1984;23-29.
30. Frederickson R.C.A., Smits S.E. Time course of dependence and tolerance development in rats treated with 'slow release' morphine suspensions. Res. Commun. Chem. Pathol. Pharmacol. 5:1973;867-870.
31. Gogas K.R., Cho H.J., Botchkina G.I., Levine J.D., Basbaum A.I. Inhibition of noxious stimulus-evoked pain behaviors and neuronal fos-like immunoreactivity in the spinal cord of the rat by supraspinal morphine. Pain. 65:1996;9-15.
32. Gogas K.R., Presley R.W., Levine J.D., Basbaum A.I. The antinociceptive action of supraspinal opioids results from an increase in descending inhibitory control: correlation of nociceptive behavior and c-Fos expression. Neuroscience. 42(3):1991;617-628.
33. Hammond D.L., Presley R.W., Gogas K.R., Basbaum A.I. Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat. J. Comp. Neurol. 315:1992;244-253.
34. Hargreaves K.M., Dubner R., Brown F., Flores C., Joris J.L. A new and sensitive method for measuring thermal antinociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
35. Hassan A.H.S., Ableitner A., Stein C., Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in inflamed tissue. Neuroscience. 55:1993;185-195.
36. Honoré P., Buritova J., Besson J.-M. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin. Eur. J. Pharmacol. 272:1995;249-259.
37. Honoré P., Catheline G., Le Guen S., Besson J.-M. Chronic treatment with systemic morphine induced tolerance to the systemic and peripheral antinociceptive effects of morphine on both carrageenin induced mechanical hyperalgesia and spinal c-Fos expression in awake rats. Pain. 71:1997;99-108.
38. Honoré P., Chapman V., Buritova J., Besson J.-M. When is the maximal effect of pre-administered systemic morphine on carrageenin evoked spinal c-Fos expression in the rat? Brain Res. 705:1995;91-96.
39. Hsu S., Raine L., Fanger H. Use of avidin-biotin-peroxydase complex (ABC) in immunoperoxydase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J. Histochem. Cytochem. 29:1981;577-580.
40. Hunt S.P., Pini A., Evan G.I. Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature. 328:1987;630-632.
41. Iadarola M.J., Brady L.S., Draisci G., Dubner R. Enhancement of dynorphin gene expression in spinal cord following experimental inflammation: stimulus specificity, behavioral parameters and opioid receptor binding. Pain. 35:1988;313-326.
42. Ibuki T., Dunbar S.A., Yaksh T.L. Effect of transient naloxone antagonism on tolerance development in rats receiving continuous spinal morphine infusion. Pain. 70:1997;125-132.
43. Joris J.L., Costello A., Dubner R., Hargreaves K.M. Opiates suppress carrageenan-induced edema and hyperthermia at doses that inhibit hyperalgesia. Pain. 43:1990;95-103.
44. Kayser V., Guilbaud G. Local and remote modifications of nociceptive sensitivity during carrageenin-induced inflammation in the rats. Pain. 28:1987;99-107.
45. Kolesnikov Y.A., Jain S., Wilson R.N., Pasternak G.W. Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance. J. Pharmacol. Exp. Ther. 279(2):1996;502-506.
46. LaMotte C.C., Pert C.B., Snyder S.H. Opiate receptor binding in primate spinal cord: distribution and changes after dorsal root section. Brain Res. 112:1976;407-412.
47. M.-C. Lombard, D. Besse J.-M. Besson, Opioid receptors in the superficial layers of the rat spinal cord: functional implications in pain processing, in: F. Nyberg, H.S. Sharma, Z. Wiesenfeld-Hallin (Eds.), Progress in Brain Research: Neuropeptides in the Spinal Cord, Vol. 104, Elsevier, 1995, pp. 77-92.
48. Lombard M.-C., Besson J.-M. Attempts to gauge the relative importance of pre- and postsynaptic effects of morphine on the transmission of noxious messages in the dorsal horn of the rat spinal cord. Pain. 37:1989;335-345.
49. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18(1):1995;22-29.
50. Mao J., Price D.D., Mayer D.J. Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C. J. Neurosci. 14:1994;2301-2312.
51. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
52. Noguchi K., Dubner R., Ruda M.A. Preproenkephalin mRNA in spinal dorsal horn neurons is induced by peripheral inflammation and is co-localized with Fos and Fos-related proteins. Neuroscience. 46:1992;561-570.
53. Noguchi K., Kowalski K., Traub R.J., Solodkin A., Iadarola M.J., Ruda M.A. Dynorphin expression and Fos-like immunoreactivity following inflammation induced hyperalgesia are colocalized in spinal cord neurons. Mol. Brain Res. 10:1991;227-233.
54. Paronis C.A., Holtzman S.G. Development of tolerance to the analgesic activity of μ agonists after continuous infusion of morphine, meperidine or fentanyl in rats. J. Pharmacol. Exp. Ther. 262(1):1992;1-9.
55. Presley R.W., Menétrey D., Levine J.D., Basbaum A.I. Systemic morphine suppresses noxious stimulus-evoked Fos protein-like immunoreactivity in the rat spinal cord. J. Neurosci. 10(1):1990;323-335.
56. Roerig S.C., O'Brien S.M., Fujimoto J.M., Wilcox G.L. Tolerance to morphine analgesia: decreased multiplicative interaction between spinal and supraspinal sites. Brain Res. 308:1984;360-363.
57. Rohde D.S., Detweiler D.J., Basbaum A.I. Formalin-evoked Fos expression in spinal cord is enhanced in morphine-tolerant rats. Brain Res. 766:1997;93-100.
58. Russell R.D., Leslie J.B., Su Y.-F., Watkins W.D., Chang K.-J. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of μ and delta spinal opioid receptors. J. Pharmacol. Exp. Ther. 240(1):1987;150-158.
59. Stein C. Peripheral mechanisms of opioid analgesia. Anesth. Analg. 76:1993;182-191.
60. Stein C. Morphine-a 'local analgesic'. IASP. 3(1):1995;1-4.
61. Stein C., Hassan A.H.S., Przewlocki R., Gramsch C., Peter K., Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. U.S.A. 87:1990;5935-5939.
62. Stein C., Pflüger M., Yassouridis A., Hölzl J., Hassan A.H.S., Lehrberger K. No tolerance to peripheral morphine analgesia in presence of increased opioid expression in inflamed tissue. Anesthesiology. 85(3 A):1996;A792-A790. (Abstract).
63. C. Stein, M. Schäfer, P.J. Cabot, Q. Zhang, L. Zhou, L. Carter, Opioids and inflammation, in: D. Borsook (Ed.), Molecular Neurobiology of Pain, Progress in Pain Research and Management, Vol. 9, IASP Press, Seattle, 1997, pp. 25-43.
64. Stevens C.W. Perspectives on opioid tolerance from basic research: behavioural studies after spinal administration in rodents. Cancer Surv. 1(21):1994;25-47.
65. Stevens C.W., Yaksh T.L. Time course characteristics of tolerance development to continuously infused antinociceptive agents in rats spinal cord. J. Pharmacol. Exp. Ther. 251(1):1989;216-223.
66. Tyler C.B., Advokat C. Investigation of 'cross-tolerance' between systemic and intrathecal morphine in rats. Physiol. Behav. 37:1986;27-32.
67. Tölle T.R., Castro-Lopez J.M., Coimbra A., Zieglgänsberger W. Opiates modify induction of c-fos proto-oncogene in the spinal cord of the rat following noxious stimulation. Neurosci. Lett. 111:1990;46-51.
68. T.R. Tölle, J.M. Castro-Lopez, W. Zieglgänsberger, C-fos induction in the spinal cord following noxious stimulation: prevention by opiates but not by NMDA antagonists, in: M.R. Bond, J.E. Charlton, C.J. Woolf (Eds.), Proceedings of the VIth World Congress on Pain, Elsevier, Amsterdam, 1991, pp. 299-305.
69. Tölle T.R., Herdegen T., Schadrack J., Bravo R., Zimmermann M., Zieglgänsberger W. Application of morphine prior to noxious stimulation differentially modulates expression of Fos, Jun and Krox-24 proteins in rat spinal cord neurons. Neuroscience. 58:1994;305-321.
70. Tölle T.R., Schadrack J., Castro-Lopez J.M., Evan G.I., Roques B.P., Zieglgänsberger W. Effects of Kelatorphan and morphine before and after noxious stimulation on immediate-early gene expression in rat spinal cord neurons. Pain. 56:1994;103-112.
71. S. Williams, A. Pini, G.I. Evan, S.P. Hunt, Molecular events in the spinal cord following sensory stimulation, in: F. Cervero, J.G. Bennett, M.P. Headley (Eds.), Processing of Sensory Information in the Superficial Dorsal Horn of the Spinal Cord, Plenum, New York, 1989, pp. 273-270.
72. Winter C.A., Risley E.A., Nuss G.W. Carrageenan-induced edema in hind paw of the rat as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 111:1962;544-547.
73. T.L. Yaksh, Tolerance: factors involved in changes in the dose-effect relationship with chronic drug exposure, in: A.I. Basbaum, J.-M. Besson (Eds.), Towards a New Pharmacotherapy of Pain, Wiley, New York, 1991, pp. 157-179.
74. Yaksh T.L., Kohl R.L., Rudy T.A. Induction of tolerance and withdrawal in rats receiving morphine in the spinal subarachnoid space. Eur. J. Pharmacol. 42:1977;275-284.
75. T.L. Yaksh, C.W. Stevens, Properties of the modulation of spinal nociceptive transmission by receptor-selective agents, in: R. Dubner, G.F. Gebhart, M.R. Bond (Eds.), Proceedings of the Vth World Congress on Pain, Elsevier, 1988, pp. 417-435.
76. Yoburn B.C., Lufty K., Azimuddin S., Sierra V. Differentiation of spinal and supraspinal opioid receptors by morphine tolerance. Life Sci. 46(5):1990;343-350.
77. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.